Drug Type Interleukins |
Synonyms- |
Target |
Action modulators |
Mechanism IL-22R modulators(Interleukin-22 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | Denmark | 21 May 2022 |